The University of Pittsburgh announced today a new partnership with Vizzhy Inc., a global leader in artificial intelligence health care technology. Together, Pitt and Vizzhy will launch GAINMED, an AI-powered health care platform delivering P5 Medicine—predictive, preventive, personalized, precision and participatory care.
A further component of this initiative is the establishment of the Pitt-Vizzhy Longevity Labs, in partnership with Illumina Inc., providing multiomics laboratory services to expand precision medicine across the United States and globally.
Multiomics integrates various layers of biological information—genomic, metabolomic, proteomic, lipidomic, transcriptomic, microbiomic, epigenomic, pharmacogenomic and others—to get a complete picture of a person’s biology.
“The number one reason GAINMED chose Pittsburgh is Dr. Anantha Shekhar, whose bold vision for precision medicine, translational research and real-time clinical implementation sets Pittsburgh apart from any other city,” says Vishnu Vardhan, Vizzhy Inc. cofounder. “His leadership has built an environment where data science, clinical care and human biology converge.”
Shekhar is senior vice chancellor for the health sciences and John and Gertrude Petersen Dean of the School of Medicine at the University of Pittsburgh.
Personalized medicine is evolving rapidly by integrating multiomics, systems biology and AI, enabling a new model of health care that optimizes individual wellness and prevents disease through early detection and reversal. This combination of biological and digital insight allows clinicians to detect transitions from wellness to illness before symptoms occur, and to intervene with precision.
GAINMED’s launch in Pittsburgh marks a historic step in moving from a sick care system to a true health care system.
“This is more than just a scientific effort; it’s a public health mission,” says Shekhar. “Pittsburgh has the infrastructure, the institutions and, most importantly, the people to lead the world in proactive, personalized, accessible and ethical health care. We want every citizen of Pennsylvania and beyond to benefit from the future we’re building here.”
Participating corporate members in the partnership announced today include L&T-Cloudfiniti, LTIMindtree, Illumina Inc., AWS, NVIDIA, Thermo Fisher Scientific, and others.
Following the announcement, more than a dozen thought leaders in technology, medicine, systems biology and other disciplines—scientists from across the globe with expertise in applying AI to health care—spoke at the Pitt Med + AI: Transforming Global Health Symposium, discussing recent advancements, sharing insights and exploring collaborative opportunities to advance P5 Medicine, as well as addressing data standardization, trust, security and the importance of widespread data sharing.
About the University of Pittsburgh School of Medicine
As one of the leading academic centers for biomedical research in the United States, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition.
About Vizzhy
Vizzhy is a company based in Bengaluru, India, that is revolutionizing health care by integrating advanced multiomics technologies, technology-enabled health monitoring and generative AI to decode an individual’s metabolic signature.
RSS